Wolfgang Sieghart

Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 Activation

Guobin He, Guann‐Yi Yu, Vladislav Temkin et al. · Cancer Cell · 2010 · 425 citations · Full text

Inflammation, Cancer Research, Reductive Stress +11

Nonselective β Blockers Increase Risk for Hepatorenal Syndrome and Death in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis

Mattias Mandorfer, Simona Bota, Philipp Schwabl et al. · Gastroenterology · 2014 · 369 citations

Hepatology, Liver Physiology, Hepatorenal Syndrome +10

Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study

Lorenza Rimassa, Eric Assénat, Markus Peck‐Radosavljevic et al. · The Lancet Oncology · 2018 · 340 citations

Second-line Treatment, Hepatology, Medicine +10

The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma

Wolfgang Sieghart, Florian Hucke, Matthias Pinter et al. · Hepatology · 2013 · 333 citations · Full text

Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

Mattias Mandorfer, K Kozbial, Philipp Schwabl et al. · Journal of Hepatology · 2016 · 298 citations

Hepatology, Viral Hepatitis, Immunology +8